Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
QuintilesIMS
Queensland Health
Chubb
Colorcon
McKesson
Teva
Medtronic
Dow

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021140

« Back to Dashboard

NDA 021140 describes IMODIUM MULTI-SYMPTOM RELIEF, which is a drug marketed by J And J Consumer Inc and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the IMODIUM MULTI-SYMPTOM RELIEF profile page.

The generic ingredient in IMODIUM MULTI-SYMPTOM RELIEF is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for 021140
Tradename:IMODIUM MULTI-SYMPTOM RELIEF
Applicant:J And J Consumer Inc
Ingredient:loperamide hydrochloride; simethicone
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021140
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET;ORAL 021140 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-338 50580-338-60 2 CARTON in 1 PACKAGE (50580-338-60) > 1 BOTTLE in 1 CARTON (50580-338-30) > 30 TABLET in 1 BOTTLE
IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET;ORAL 021140 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-338 50580-338-12 2 BLISTER PACK in 1 CARTON (50580-338-12) > 6 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength2MG;125MG
Approval Date:Nov 30, 2000TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jul 17, 2017Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021140

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET;ORAL 021140-001 Nov 30, 2000 ➤ Subscribe ➤ Subscribe
J And J Consumer Inc IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET;ORAL 021140-001 Nov 30, 2000 ➤ Subscribe ➤ Subscribe
J And J Consumer Inc IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET;ORAL 021140-001 Nov 30, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
McKesson
Teva
AstraZeneca
Merck
Colorcon
QuintilesIMS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot